CNS Pharmaceuticals

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CNSP and other ETFs, options, and stocks.

About CNSP

CNS Pharmaceuticals, Inc. is a preclinical stage pharmaceutical company, which engages in the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. Its product pipeline includes berubicin, and CNS-12. 

CEO
John M. Climaco
CEOJohn M. Climaco
Employees
5
Employees5
Headquarters
Houston, Texas
HeadquartersHouston, Texas
Founded
2017
Founded2017
Employees
5
Employees5

CNSP Key Statistics

Market cap
3.36M
Market cap3.36M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
53.45K
Average volume53.45K
High today
$2.60
High today$2.60
Low today
$2.39
Low today$2.39
Open price
$2.60
Open price$2.60
Volume
57.68K
Volume57.68K
52 Week high
$41.40
52 Week high$41.40
52 Week low
$2.39
52 Week low$2.39

CNSP Earnings

-$0.16
-$0.11
-$0.05
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated
per share
Estimated per share
Actual
Expected Mar 2, Pre-Market
ActualExpected Mar 2, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.